San Diego-based CoDa Therapeutics, a developer of biopharmaceuticals for wound care, has scored $6M in a credit facility, according to the firm's lender. Square 1 Bank said that it has provided CoDa Therapeutics with a $6M term loan. Terms of that loan were not disclosed. CoDa Therapeutics is backed by Domain Associates, GBS Venture Partners, and BioPacificVentures. The company last raised a round of venture funding in April, worth $19M.
Top NewsThursday, October 6, 2011
CoDa Therapeutics Lands $6M Credit Facility